Get startedLog in
    Picture of Sumitomo Pharma logo

    4506 — Sumitomo Pharma News Story

    0.000.00%
    jp flag iconLast trade - 00:00
    HealthcareHighly SpeculativeLarge CapValue Trap
    All News

    Submission Of Application Of Manufacturing And Marketing Authorization For Ips Cell-Derived Dopaminergic Neural Progenitor Cells In Japan

    Picture of Sumitomo Pharma logoSumitomo Pharma
    05/08/2025 04:51
    Aug 5 (Reuters) - Sumitomo Pharma Co Ltd 4506.T:

SUMITOMO PHARMA CO LTD: SUBMISSION OF APPLICATION OF MANUFACTURING AND MARKETING AUTHORIZATION FOR IPS CELL-DERIVED DOPAMINERGIC NEURAL PROGENITOR CELLS IN JAPAN

Source text: ID:nTSte814b2

Further company coverage: 4506.T

 (Reporting by Tokyo Newsroom)

 ((+81345201189;))

    Recent news on Sumitomo Pharma

    See all news